Javascript must be enabled to continue!
STAT3-mediated ferroptosis is involved in α-synuclein pathology
View through CrossRef
AbstractBackgroundOligomeric α-synuclein (α-syn) can activate microglia to drive the early stages of Parkinson's disease (PD) pathogenesis. Our previous studies have found a significant expression difference between the lncRNA IL6ST-AS and its antisense RNA IL6ST in the cerebrospinal fluid of PD patients. Furthermore, in α-syn-induced HMC3 cells, a decline in IL6ST and its downstream target JAK2/STAT3 were also observed. Accumulating investigations have illustrated that STAT3 regulates the expression of ferroptosis-related genes and further influences the proliferation of cells.MethodsThe role and mechanisms of IL6ST/JAK2/STAT3 axis in α-syn induced HMC3 cells and PD mouse models were explored by Western blot or immunohistochemistry. Transcriptome sequencing of HMC3 cells exposed to α-syn oligomers and PD mouse models were performed. The STAT3 activator and the STAT3 inhibitor were used to regulate the expression of STAT3. qPCR was used to detect the expression of ferroptosis regulation genes (FRG) in HMC3 cells induced by α-syn or STAT3 inhibitor. ROS, lipid peroxidation and iron levels were measured by flow cytometry.ResultsWe found that α-syn could impair cell activity and stalely inhibit the IL6ST/ STAT3/HIF-1α pathway in α-syn-induced HMC3 cells. Besides, we performed transcriptomic analysis for α-syn-induced HMC3 cells and in α-syn-induced PD mouse models and GSEA indicated an association with ferroptosis. The reduction in P-STAT3 resulted in the lower expression of HIF-1α and the transcriptional activation of ferroptosis positive regulation (FPR) genes. P-STAT3 mediated ferroptotic cell death in α-syn-induced HMC3 cells by modulating lipid peroxidation and iron metabolism levels. An in vivo study revealed that the IL6ST/JAK2/STAT3/HIF-1α pathway was upregulated in PD mouse models.ConclusionsSTAT3 was an important factor that regulates ferroptosis in α-syn pathology via the JAK2/STAT3/HIF-1α axis. Our research illustrated the relationship of the JAK2/STAT3/HIF-1α axis and ferroptosis in the pathological process of α-syn both in vitro and in vivo, providing new topics of interest regarding the inflammation damage hypothesis and pathogenesis in PD.
Research Square Platform LLC
Title: STAT3-mediated ferroptosis is involved in α-synuclein pathology
Description:
AbstractBackgroundOligomeric α-synuclein (α-syn) can activate microglia to drive the early stages of Parkinson's disease (PD) pathogenesis.
Our previous studies have found a significant expression difference between the lncRNA IL6ST-AS and its antisense RNA IL6ST in the cerebrospinal fluid of PD patients.
Furthermore, in α-syn-induced HMC3 cells, a decline in IL6ST and its downstream target JAK2/STAT3 were also observed.
Accumulating investigations have illustrated that STAT3 regulates the expression of ferroptosis-related genes and further influences the proliferation of cells.
MethodsThe role and mechanisms of IL6ST/JAK2/STAT3 axis in α-syn induced HMC3 cells and PD mouse models were explored by Western blot or immunohistochemistry.
Transcriptome sequencing of HMC3 cells exposed to α-syn oligomers and PD mouse models were performed.
The STAT3 activator and the STAT3 inhibitor were used to regulate the expression of STAT3.
qPCR was used to detect the expression of ferroptosis regulation genes (FRG) in HMC3 cells induced by α-syn or STAT3 inhibitor.
ROS, lipid peroxidation and iron levels were measured by flow cytometry.
ResultsWe found that α-syn could impair cell activity and stalely inhibit the IL6ST/ STAT3/HIF-1α pathway in α-syn-induced HMC3 cells.
Besides, we performed transcriptomic analysis for α-syn-induced HMC3 cells and in α-syn-induced PD mouse models and GSEA indicated an association with ferroptosis.
The reduction in P-STAT3 resulted in the lower expression of HIF-1α and the transcriptional activation of ferroptosis positive regulation (FPR) genes.
P-STAT3 mediated ferroptotic cell death in α-syn-induced HMC3 cells by modulating lipid peroxidation and iron metabolism levels.
An in vivo study revealed that the IL6ST/JAK2/STAT3/HIF-1α pathway was upregulated in PD mouse models.
ConclusionsSTAT3 was an important factor that regulates ferroptosis in α-syn pathology via the JAK2/STAT3/HIF-1α axis.
Our research illustrated the relationship of the JAK2/STAT3/HIF-1α axis and ferroptosis in the pathological process of α-syn both in vitro and in vivo, providing new topics of interest regarding the inflammation damage hypothesis and pathogenesis in PD.
Related Results
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract
Background The STAT3 pathway may drive prostate cancer (PCa) progression to metastatic castration-resistant prostate cancer (mCRPC). STAT3 may serve as a go...
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract
Approximately 13% of women are diagnosed with invasive breast cancer. Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor t...
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract
STAT3 is involved in the pathogenesis of many malignancies, so we developed an anti-STAT3 VHH (variable region of the heavy chain), SBT-100, that internaliz...
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract
Cancer is often characterized by aberrant gene expression patterns that alter cellular function. Such alterations are commonly caused by the inappropriat...
Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology
Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology
Abstract
Research background and purpose
Osteoporosis (OP) is one of the most common bone diseases worldwide, characterized by low bone mineral density and susceptibility ...
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Abstract
Abstract 2849
Poster Board II-825
Histone deacetylase inhibitors (HDACi) are emerging as a potential therapy for Multiple Myel...
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Abstract 5436: Novel single-domain antibody (sdAb), SBT-100, localizes in the cytoplasm to inhibit IL-6 mediated P-STAT3 nuclear translocation in cancer cells
Abstract 5436: Novel single-domain antibody (sdAb), SBT-100, localizes in the cytoplasm to inhibit IL-6 mediated P-STAT3 nuclear translocation in cancer cells
Abstract
BACKGROUND: Interleukin-6 (IL-6) is a multifunctional cytokine that is involved in immune defense and plays an important role in biologic activities of cell...

